POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.290
https://www.valueinhealthjournal.com/article/S1098-3015(21)02085-4/fulltext
Title :
POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02085-4&doi=10.1016/j.jval.2021.11.290
First page :
Section Title :
Open access? :
No
Section Order :
11069